Dr. George Lasezkay Joins Acucela as Executive Vice President, Legal Affairs
SEATTLE--(BUSINESS WIRE)--Acucela Inc. (TOKYO: 4589) (“Acucela” or the “Company”), a clinical-stage biotechnology company that specializes in discovering and developing novel drug candidates to potentially treat and slow the progression of sight-threatening ophthalmic diseases, announced today that it has hired Dr. George Lasezkay as Executive Vice President, Legal Affairs, effective Aug. 24. Dr. Lasezkay will head up Acucela’s legal team and be the primary legal advisor to CEO Ryo Kubota and t
